Diagnostics News and Research RSS Feed - Diagnostics News and Research

Surmodics introduces advanced immunoassay stabilizer StabilBlock

Surmodics introduces advanced immunoassay stabilizer StabilBlock

Surmodics, Inc., the global leader in chemical components for in vitro diagnostic (IVD) tests and microarrays, today announced the launch and immediate availability of StabilBlock, its most advanced Immunoassay Stabilizer. [More]
Recombinant antigens and antibodies for the Zika virus

Recombinant antigens and antibodies for the Zika virus

Anglo-American life science firm AMSBIO announces a new range of recombinant antigens and antibodies for Zika virus, which are suited for the development of rapid assays and to overcome the problem of cross-reactivity with related viruses. [More]
Changes in volume of patients in trauma centers can influence patient outcomes

Changes in volume of patients in trauma centers can influence patient outcomes

University of Pittsburgh School of Medicine researchers have demonstrated for the first time that changes over time in the volume of patients seen by trauma centers influence the likelihood of seriously injured patients living or dying. [More]
Researchers identify specific pathways involved in development of mucormycosis

Researchers identify specific pathways involved in development of mucormycosis

Research published today in the journal, Nature Communications, provides new insights into the evolution of Mucorales fungi, which cause a fatal infection in ever-increasing segments of patient population, and several molecular pathways that might be exploited as potential therapeutic or diagnostic targets. [More]
Predictive power of computational toxicology demonstrated with crowd-sources scientific challenge

Predictive power of computational toxicology demonstrated with crowd-sources scientific challenge

Results of the Systems Toxicology Computational Challenge have demonstrated how transcriptomics information present in the blood can be used to predict whether people have been exposed or not exposed to specific toxicants. [More]
Study highlights role of BCL11A gene in intellectual disability syndrome

Study highlights role of BCL11A gene in intellectual disability syndrome

Scientists at the Wellcome Trust Sanger Institute and Max Planck Institute for Psycholinguistics have found a gene responsible for an intellectual disability disorder and proven how it works. [More]
Advances in NIRS technologies offer reduced health-care costs, better patient comfort

Advances in NIRS technologies offer reduced health-care costs, better patient comfort

The latest advances in near-infrared spectroscopy technologies are enabling development of new capabilities in diagnosis and treatment of disease, offering reduced health-care costs, portability, increased sensitivity, higher patient comfort, and better quality of life. [More]
GSK and University of Leicester team up to develop novel drugs to treat blood cancer

GSK and University of Leicester team up to develop novel drugs to treat blood cancer

A collaboration between the University of Leicester and global pharmaceutical company GlaxoSmithKline has been established to discover and develop novel medicines to treat aggressive forms of blood cancer. [More]
Free online World Sepsis Congress sponsored by Radiometer

Free online World Sepsis Congress sponsored by Radiometer

Radiometer is proud to announce that it is sponsoring the 1st World Sepsis Congress, from the 8th to the 9th of September 2016. Organized by the Global Sepsis Alliance, this free online event will give participants the chance to hear experts from around the world discuss the challenges and opportunities in the battle against this life-threatening illness. [More]
Researchers show porous silicon nanoparticles could be harmless to diagnose and treat cancer

Researchers show porous silicon nanoparticles could be harmless to diagnose and treat cancer

The Lomonosov Moscow State University researchers in collaboration with their German colleagues have succeeded in proving that silicon nanoparticles can be applied to diagnose and cure cancer. [More]
Roche Diagnostics launches new mobile and tablet app to remotely manage POCCs' workload

Roche Diagnostics launches new mobile and tablet app to remotely manage POCCs' workload

Roche Diagnostics is today launching the first mobile and tablet application specifically designed to help point-of-care coordinators manage their workload remotely. [More]
Thread-based device could be sutured through tissues to gather real time diagnostic data

Thread-based device could be sutured through tissues to gather real time diagnostic data

For the first time, researchers led by Tufts University engineers have integrated nano-scale sensors, electronics and microfluidics into threads - ranging from simple cotton to sophisticated synthetics - that can be sutured through multiple layers of tissue to gather diagnostic data wirelessly in real time, according to a paper published online July 18 in Microsystems & Nanoengineering. [More]
Chelsea and Westminster Hospital deploys new imaging systems from Siemens Healthineers following A&E expansion

Chelsea and Westminster Hospital deploys new imaging systems from Siemens Healthineers following A&E expansion

Chelsea and Westminster Hospital in West London has enhanced its provision of imaging services to ensure an efficient workflow throughout A&E as part of the first phase of a major redevelopment of the Emergency Department which includes a new imaging suite. [More]
Nuffield Health enhances breast screening service with MAMMOMAT Inspiration systems from Siemens Healthineers

Nuffield Health enhances breast screening service with MAMMOMAT Inspiration systems from Siemens Healthineers

The UK’s largest not-for-profit healthcare provider Nuffield Health has as part of its wider investment programme improved its breast screening service with a technology refresh which includes six systems from Siemens Healthineers. [More]
Diabetes Professional Care conference unveils speaker line-up for 2016

Diabetes Professional Care conference unveils speaker line-up for 2016

Diabetes Professional Care 2016, the leading free-to-attend two-day CPD accredited conference and exhibition has unveiled its speaker line-up for 2016, which includes keynote presentations from NHS England and The Diabetes Think Tank. [More]
Study produces most detailed picture to date of genetics underlying type 2 diabetes

Study produces most detailed picture to date of genetics underlying type 2 diabetes

The largest study of its kind into type 2 diabetes has produced the most detailed picture to date of the genetics underlying the condition. [More]
New mass spectrometry imaging protocol allows analysis of metabolite composition of tissues

New mass spectrometry imaging protocol allows analysis of metabolite composition of tissues

In biomedical research, working with tissue samples is indispensable because it permits insights into the biological reality of patients, for example, in addition to those gained from Petri dishes and computer simulations. [More]
Researchers identify novel therapeutic monoclonal antibodies from Zika-infected patients

Researchers identify novel therapeutic monoclonal antibodies from Zika-infected patients

A team of researchers from the Institute for Research in Biomedicine and the Swiss biotech company Humabs BioMed SA has identified novel therapeutic monoclonal antibody candidates isolated from Zika-infected patients and new strategies for Zika virus diagnostics. [More]
Research shows biglycan molecule plays key role in determining tumour malignancy

Research shows biglycan molecule plays key role in determining tumour malignancy

Researchers at Hokkaido University in Japan have demonstrated that a molecule, called biglycan, plays an intrinsic role in attracting tumour cells toward the inner wall of tumour blood vessels. [More]
Expanding the potential of existing cancer therapies: an interview with Dr Mark Rutstein

Expanding the potential of existing cancer therapies: an interview with Dr Mark Rutstein

Cancer remains a leading cause of death worldwide, and the global cancer burden is expected to increase by 70 percent over the next two decades. [More]
Advertisement
Advertisement